Connect to other sites within the UBM Medica Network
Nomograms Help Predict Survival Outcomes in Osteosarcoma Patients
A retrospective study was used to develop nomograms predictive of both metastasis-free and overall survival for patients with nonmetastatic osteosarcoma.
Liver Abnormality in 28-Year-Old Patient
A 28-year-old woman with a history of nephrolithiasis has an abdomen CT scan to investigate an abnormality in the liver. What is your diagnosis?
Carbonyl Compounds in Breath Could Help Diagnose Lung Cancer
Six carbonyl compounds in exhaled breath can effectively discriminate between lung cancer patients and healthy patients, says a new study.
Carfilzomib Gets Expanded FDA Approval for Multiple Myeloma
The FDA approved the proteasome inhibitor carfilzomib for the treatment of multiple myeloma, when used in combination with lenalidomide and dexamethasone.
Younger CRC Patients Often Have Hereditary Syndromes
Patients diagnosed with colorectal cancer at younger ages are more likely to have an underlying hereditary syndrome than older patients, according to a new study.
Gemcitabine With EBRT Shows Promise in Soft-Tissue Sarcoma
In a phase I study, gemcitabine given concurrently with fixed-dose EBRT showed promising results following surgery in patients with high-risk soft-tissue sarcoma.
Two Inexpensive Drugs Can Reduce Breast Cancer Deaths
A pair of studies suggest that aromatase inhibitors and bisphosphonates can each improve survival for postmenopausal women with early breast cancer.
RT Offers Little to No Survival Boost in Early Breast Cancer
Two trials reported marginal or no improvement in survival with nodal irradiation in early breast cancer patients, though reductions were seen in recurrence.
Tivantinib With Erlotinib Fails to Improve OS in NSCLC
Adding tivantinib to erlotinib improved progression-free survival but not overall survival in patients with previously treated non-small-cell lung cancer.
Circulating DNA Offers Real-Time Genotype Information in CRC
The use of BEAMing technology on circulating DNA to identify multiple mutations in real time could help guide treatment in colorectal cancer patients.
By clicking Accept, you agree to become a member of the UBM Medica Community.